Literature DB >> 28833027

Nivolumab improves survival for patients with advanced lung cancer.

Carrie Printz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28833027     DOI： 10.1002/cncr.30930

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  1 in total

1.  [A Case of Pseudoprogression During Atezolizumab Therapy 
in Lung Adenocarcinoma].

Authors:  Xue Wang; Yi Zhao; Zhiwei Chen
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2019-06-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.